Evaluate ABUS stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ABUS? | Glauxie AI

Q: What are the risks of investing in ABUS?

Arbutus Biopharma Corporation (ABUS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Lindsay Androski. Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its... Employees: 19.

Q: How much debt does ABUS have?

Review ABUS total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ABUS a good long-term investment?

Evaluate ABUS as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ABUS?

🦉

Arbutus Biopharma Corporation (ABUS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOLindsay Androski

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference...

Key Executives

Name	Title
Andrew J. Sung	General Counsel
Lindsay Androski	President, Chief Executive Officer & Chairman
R. Hector Mackay-Dunn	Corporate Secretary
Tuan Nguyen	Chief Financial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ABUS Profile Financials

Is ABUS stock safe? How much debt does ABUS have? Is ABUS a good long-term investment?